Globus Medical Inc (GMED): Market Cap to Revenue

Symbol and logo of brand Globus Medical Inc (GMED)

High physician loyalty to Globus Medical, Inc. (GMED) instrumentation ensures a steady cash flow. Monitoring the company's P/S ratio allows for filtering out market noise and assessing real revenue demand, with 2.50 recorded as the baseline value. The robotization of clinics creates long-term lock-in to an ecosystem with margins exceeding 70%, although growth rates depend on government budgets and regulatory approvals.

GMED Globus Medical Inc P/S Multiple (07/04/2022 - 11/17/2026)

Analytical breakdowns for globusmedical.com (GMED)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:GMED Globus Medical Inc
Core merchandise of Globus Medical, Inc.

High capacity utilization of spinal implant and robot manufacturing plants during the asset integration period at Globus Medical, Inc. (GMED) directly impacts revenue generation potential. The P/S metric compares current market capitalization with sales volume, allowing investors to assess the degree of overpayment for the asset or the priced-in growth, which is clearly reflected in the price-to-sales ratio trend.

Competitors of Globus Medical, Inc.

Market Cap to Revenue Boston Scientific Corporation BSX|P/S Multiple EW (Edwards Lifesciences)|ResMed Corp (RMD) - Price to Sales|Insulet Corp - P/S Multiple|ZBH (zimmerbiomet.com) - Market Cap to Revenue Ratio|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|TMDX (TransMedics Corp) - P/S Multiple|ATEC Spine (ATEC) - Price-to-Revenue Coefficient|P/S Multiple AORT|Market Cap to Revenue Enovis Corporation ENOV|P/S Multiple IART (integralife.com)|P/S Multiple Establishment Labs Corp ESTA|BBNX - Price-to-Revenue Ratio|IRMD: Price-to-Revenue Ratio|EMBC (Embecta Corp.) - Market Cap to Revenue|Tandem Diabetes Care - Market Capitalization-to-Revenue Ratio|AXGN (Axogen Surgical) - P/S Multiple|Price to Sales SI-BONE Inc SIBN|Price-to-Revenue Ratio Orthofix Medical (OFIX)|P/S Multiple Bioventus Corp (BVS)|OrthoPediatrics Corp - Market Cap to Revenue|P/S Multiple Treace Medical Concepts TMCI|Blade Air Mobility - P/S Multiple|Price-to-Revenue Coefficient Carlsmed, Inc. CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint)|Price-to-Revenue Ratio stereotaxis.com|Market Cap to Revenue Neuronetics, Inc. (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio anikatherapeutics.com ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical Inc - Market Cap to Sales Volume|XTNT (Xtant Medical Holdings) - Market Cap to Revenue|Market Cap to Revenue Ratio NMTC|Price-to-Revenue Ratio Modular Medical Inc|Price to Sales Myomo Inc MYO|Market Cap to Revenue COCH (Envoy Medical, Inc.)|Price-to-Revenue Ratio VVOS (vivoslife.com)|enVVeno Medical Corp. - Market Cap to Revenue|Market Cap to Sales Volume SINT (sintx.com)|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|autonomix.com (AMIX) - Price-to-Revenue Ratio|Price to Sales invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - P/S Multiple|Axonics Modulation Technologies (AXNX) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (Biolase, Inc.)|Dynatronics - Market Cap to Revenue Ratio|Paragon 28, Inc. - Market Cap to Revenue|Price-to-Revenue Coefficient INVO Bio (INVO)